Eli Lilly and Company 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-24 4:30 pm Purchase | 2026-06-26 | 13G | PROQR THERAPEUTICS N.V. PRQR | ELI LILLY & Co LLY | 21,995,880 15.600% | 8,624,318 (+64.50%) | Filing |
| 2022-12-23 4:39 pm Purchase | 2022-12-21 | 13G | PROQR THERAPEUTICS N.V. PRQR | ELI LILLY & Co LLY | 13,371,562 16.600% | 9,381,586 (+235.13%) | Filing |
| 2021-09-10 1:03 pm Purchase | 2021-09-03 | 13G | PROQR THERAPEUTICS N.V. PRQR | ELI LILLY & Co LLY | 3,989,976 5.600% | 3,989,976 (New Position) | Filing |